Xiaoling Wu

1.4k total citations
54 papers, 996 citations indexed

About

Xiaoling Wu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Xiaoling Wu has authored 54 papers receiving a total of 996 indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 34 papers in Cancer Research and 8 papers in Oncology. Recurrent topics in Xiaoling Wu's work include Cancer-related molecular mechanisms research (20 papers), RNA modifications and cancer (17 papers) and MicroRNA in disease regulation (12 papers). Xiaoling Wu is often cited by papers focused on Cancer-related molecular mechanisms research (20 papers), RNA modifications and cancer (17 papers) and MicroRNA in disease regulation (12 papers). Xiaoling Wu collaborates with scholars based in China, United States and Ethiopia. Xiaoling Wu's co-authors include Dongge Cai, Yidong Wang, Xia Zhang, Jinjun Guo, Bo Ning, Hongbin Zhang, Bo Liu, Zhenzhen Zhang, Peng Yang and Yanmin Liu and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

In The Last Decade

Xiaoling Wu

51 papers receiving 984 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoling Wu China 21 758 543 170 83 79 54 996
Shengni Hua China 16 829 1.1× 587 1.1× 253 1.5× 122 1.5× 76 1.0× 22 1.1k
Songbing He China 20 736 1.0× 519 1.0× 194 1.1× 112 1.3× 61 0.8× 34 957
Quan Hao China 18 659 0.9× 574 1.1× 167 1.0× 69 0.8× 94 1.2× 37 994
Xiao Feng China 15 580 0.8× 630 1.2× 149 0.9× 68 0.8× 86 1.1× 18 900
Guosong Jiang China 15 651 0.9× 399 0.7× 110 0.6× 57 0.7× 54 0.7× 24 815
Haifeng Zhang China 14 671 0.9× 550 1.0× 100 0.6× 55 0.7× 83 1.1× 32 895
Shucai Yang China 13 509 0.7× 317 0.6× 230 1.4× 95 1.1× 154 1.9× 24 793
Angélique Gougèlet France 15 602 0.8× 348 0.6× 184 1.1× 78 0.9× 107 1.4× 23 976
Leire Gárate Spain 23 1.2k 1.6× 573 1.1× 154 0.9× 48 0.6× 106 1.3× 32 1.5k

Countries citing papers authored by Xiaoling Wu

Since Specialization
Citations

This map shows the geographic impact of Xiaoling Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoling Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoling Wu more than expected).

Fields of papers citing papers by Xiaoling Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoling Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoling Wu. The network helps show where Xiaoling Wu may publish in the future.

Co-authorship network of co-authors of Xiaoling Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoling Wu. A scholar is included among the top collaborators of Xiaoling Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoling Wu. Xiaoling Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Xiaoling, Yiran Chen, Wenzhi He, et al.. (2025). UBE2Q2 promotes tumor progression and glycolysis of hepatocellular carcinoma through NF-κB/HIF1α signal pathway. Cellular Oncology. 48(3). 637–654. 2 indexed citations
2.
3.
Wu, Xiaoling, et al.. (2024). Oct4 activates IL-17A to orchestrate M2 macrophage polarization and cervical cancer metastasis. Cancer Immunology Immunotherapy. 73(4). 73–73. 13 indexed citations
4.
Gao, Jun, Yuan Fang, Jiafeng Chen, et al.. (2023). Methyltransferase like 3 inhibition limits intrahepatic cholangiocarcinoma metabolic reprogramming and potentiates the efficacy of chemotherapy. Oncogene. 42(33). 2507–2520. 28 indexed citations
5.
Chen, Xi, Weijie Ma, Ye Yao, et al.. (2021). Serum deprivation-response protein induces apoptosis in hepatocellular carcinoma through ASK1-JNK/p38 MAPK pathways. Cell Death and Disease. 12(5). 425–425. 32 indexed citations
6.
Ma, Weijie, Ye Yao, Gang Xu, et al.. (2021). Identification of a seven-long non-coding RNA signature associated with Jab1/CSN5 in predicting hepatocellular carcinoma. Cell Death Discovery. 7(1). 178–178. 7 indexed citations
7.
Jiang, Xiang, Yingyi Liu, Ganggang Wang, et al.. (2020). Up-regulation of CLIC1 activates MYC signaling and forms a positive feedback regulatory loop with MYC in Hepatocellular carcinoma.. PubMed Central. 10(8). 2355–2370. 16 indexed citations
8.
9.
Jiang, Xiang, Ganggang Wang, Yingyi Liu, et al.. (2020). A novel long non-coding RNA RP11-286H15.1 represses hepatocellular carcinoma progression by promoting ubiquitination of PABPC4. Cancer Letters. 499. 109–121. 27 indexed citations
10.
Chen, Pan, Qi Liu, & Xiaoling Wu. (2019). <p>HIF1α/miR-520a-3p/AKT1/mTOR Feedback Promotes The Proliferation And Glycolysis Of Gastric Cancer Cells</p>. Cancer Management and Research. Volume 11. 10145–10156. 25 indexed citations
11.
Wu, Xiaoling, et al.. (2017). Matrine inhibits the metastatic properties of human cervical cancer cells via downregulating the p38 signaling pathway. Oncology Reports. 38(2). 1312–1320. 25 indexed citations
12.
Fu, Sidney W., Woojin Lee, Xiaoling Wu, et al.. (2016). miRNAs as potential biomarkers in early breast cancer detection following mammography. Cell & Bioscience. 6(1). 6–6. 21 indexed citations
13.
Tang, Shanhong, Jianping Qin, Weihui Liu, et al.. (2015). Overexpression of p28GANK accelerates the metastasis of oesophageal squamous cell carcinoma. Molecular Medicine Reports. 11(6). 4291–4296. 2 indexed citations
14.
Wang, Yidong, et al.. (2014). Interleukin 17A Promotes Gastric Cancer Invasiveness via NF-κB Mediated Matrix Metalloproteinases 2 and 9 Expression. PLoS ONE. 9(6). e96678–e96678. 45 indexed citations
15.
Xiao, Min, Lei Chen, Xiaoling Wu, & Fuqiang Wen. (2014). The association between the rs6495309 polymorphism in CHRNA3 gene and lung cancer risk in Chinese: a meta-analysis. Scientific Reports. 4(1). 6372–6372. 7 indexed citations
16.
Wu, Xiaoling & Peng‐Sheng Zheng. (2013). Undifferentiated embryonic cell transcription factor-1 (UTF1) inhibits the growth of cervical cancer cells by transactivating p27Kip1. Carcinogenesis. 34(7). 1660–1668. 20 indexed citations
17.
Li, Zhang, et al.. (2012). [Effects of 1,25(OH)(2)D(3) on SGC-7901 cell proliferation and tumor necrosis factor-α expression].. PubMed. 32(5). 710–3. 1 indexed citations
18.
He, Wenshan, et al.. (2011). The Ku70 −1310C/G promoter polymorphism is associated with breast cancer susceptibility in Chinese Han population. Molecular Biology Reports. 39(1). 577–583. 11 indexed citations
19.
Ren, Jinghua, et al.. (2010). Lysyl Oxidase 473 G>A Polymorphism and Breast Cancer Susceptibility in Chinese Han Population. DNA and Cell Biology. 30(2). 111–116. 22 indexed citations
20.
Zhang, Hongbin, Zhenzhen Zhang, Xia Zhang, et al.. (2009). Down-regulated miR-9 and miR-433 in human gastric carcinoma. Journal of Experimental & Clinical Cancer Research. 28(1). 82–82. 159 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shengni Hua Breakdown of academic impact, for papers by Songbing He Breakdown of academic impact, for papers by Quan Hao Breakdown of academic impact, for papers by Xiao Feng Breakdown of academic impact, for papers by Guosong Jiang Breakdown of academic impact, for papers by Haifeng Zhang Breakdown of academic impact, for papers by Shucai Yang Breakdown of academic impact, for papers by Angélique Gougèlet Breakdown of academic impact, for papers by Leire Gárate
Rankless by CCL
2026